| Literature DB >> 26504593 |
Dong Yoon Kim1, Soo Geun Joe2, Seunghee Baek3, June-Gone Kim4, Young Hee Yoon4, Joo Yong Lee4.
Abstract
Purpose. To analyze causes and prognosis of acute-onset preoperatively unknown origin vitreous hemorrhage (VH). Methods. This study included patients who underwent vitrectomy for acute-onset preoperatively unknown origin VH. The underlying causes of VH, which were identified after vitrectomy, were analyzed. And overall visual prognosis of unknown origin VH was analyzed. Risk scoring system was developed to predict visual prognosis after vitrectomy. Results. 169 eyes were included. Among these, retinal vein occlusion (RVO), retinal break, and age-related macular degeneration (AMD) were identified in 74 (43.8%), 50 (29.6%), and 21 (12.4%) patients, respectively. After vitrectomy, logMAR BCVA significantly improved from 1.93 ± 0.59 to 0.47 ± 0.71. However, postoperative BCVA in AMD eyes were significantly poorer than others. Poor visual prognosis after vitrectomy was associated with old age, poor preoperative vision in both eyes, and drusen in the fellow eye. Conclusions. RVO, retinal break, and AMD are the most common causes of acute-onset preoperatively unknown origin VH and the most common causes of VH change with age. The visual prognosis of unknown origin VH is relatively good, except among AMD patients. Older patients with poor preoperative BCVA in both eyes and patients with AMD in the fellow eye are at a higher risk of poor visual prognosis following vitrectomy.Entities:
Year: 2015 PMID: 26504593 PMCID: PMC4609453 DOI: 10.1155/2015/429251
Source DB: PubMed Journal: J Ophthalmol ISSN: 2090-004X Impact factor: 1.909
Causes of acute-onset vitreous hemorrhage (VH) of preoperatively unknown origin.
| Underlying causes of VH | Eyes, |
|---|---|
| Retinal vein occlusion | 74 (43.8%) |
| Central retinal vein occlusion (CRVO) | 0/74 (0.0%) |
| Branch retinal vein occlusion (BRVO) | 74/74 (100.0%) |
| BRVO with foveal involvement | 10/74 (13.5%) |
| Vitreous hemorrhage with retinal break | 50 (29.6%) |
| Age-related macular degeneration | 21 (12.4%) |
| Macroaneurysm | 8 (4.7%) |
| Eales disease | 3 (1.8%) |
| Coats' disease | 1 (0.6%) |
| Idiopathic | 12 (7.1%) |
| Total | 169 (100%) |
Figure 1Causes of acute-onset vitreous hemorrhage of unknown origin according to age. Among patients aged ≤60 years, retinal break was the main cause of acute-onset VH of preoperatively unknown origin. Moreover, the proportion of cases of acute-onset VH of preoperatively unknown origin that was due to retinal break declined with age. In contrast to retinal break, the proportion of vitreous hemorrhage due to wAMD increased with age. Among patients aged >60 years, RVO was the most common cause of acute-onset VH of preoperatively unknown origin. RVO, retinal vein occlusion; wAMD, wet age-related macular degeneration.
Figure 2Changes in visual acuity after vitrectomy according to postoperative diagnosis. In the retinal vein occlusion, retinal break, and idiopathic groups, BCVA significantly improved after vitrectomy. However, visual improvement was not seen after vitrectomy among patients with wet age-related macular degeneration.
Clinical characteristics of acute-onset vitreous hemorrhage (VH) of preoperatively unknown origin.
| All | RVO | wAMD | Retinal break | Other |
| |
|---|---|---|---|---|---|---|
| Number of eyes | 169 | 77 | 21 | 50 | 24 | 0.001 |
| Age (y) | 63.64 ± 12.37 | 65.36 ± 9.82 | 73.29 ± 8.30 | 58.50 ± 11.78 | 60.63 ± 17.14 | <0.001 |
| Sex (male/female) | 83/86 | 33/41 | 11/10 | 31/19 | 8/16 | 0.216† |
| Right/left | 88/81 | 38/36 | 9/12 | 29/21 | 12/12 | 0.093† |
| Follow-up duration (mo.) | 13.24 ± 14.52 | 11.34 ± 11.59 | 15.62 ± 19.19 | 15.56 ± 17.00 | 12.21 ± 12.49 | 0.360 |
| Gauge of surgery | 0.098† | |||||
| 20-gauge | 19/169 (11.2%) | 10/74 (13.5%) | 5/21 (23.8%) | 3/50 (6.0%) | 1/24 (4.2%) | |
| 23/25-gauge | 150/169 (88.8%) | 64/74 (86.5%) | 16/21 (76.2%) | 47/50 (94.0%) | 23/24 (95.8%) | |
| Tamponade | <0.001† | |||||
| No tamponade | 56/169 (33.1%) | 34/74 (45.9%) | 4/21 (19.0%) | 9/50 (18.0%) | 9/24 (37.5%) | |
| Air | 55/169 (32.5%) | 32/74 (43.2%) | 1/21 (4.8%) | 13/50 (26.0%) | 9/24 (37.5%) | |
| C3F8 | 24/169 (14.2%) | 3/74 (4.1%) | 1/21 (4.8%) | 19/50 (38.0%) | 1/24 (4.2%) | |
| Silicone oil | 34/169 (20.1%) | 5/74 (6.8%) | 15/21 (71.4%) | 9/50 (18.0%) | 5/24 (20.8%) | |
| Systemic disease | ||||||
| Hypertension | 92/169 (54.4%) | 48/74 (64.9%) | 13/21 (61.9%) | 17/50 (34.0%) | 14/24 (54.4%) | 0.006† |
| Duration (y) | 8.44 ± 7.85 | 8.55 ± 8.46 | 6.92 ± 5.39 | 6.90 ± 5.52 | 11.57 ± 9.76 | 0.329 |
| Diabetes | 20/169 (11.8%) | 9/74 (12.2%) | 2/21 (9.5%) | 7/50 (14/0%) | 2/24 (8.3%) | 0.891† |
| Duration (y) | 9.56 ± 8.46 | 7.56 ± 4.95 | 6.50 ± 4.95 | 12.71 ± 4.45 | 13.44 ± 9.50 | 0.658 |
| Anticoagulant | 51/169 (30.2%) | 34/74 (45.9%) | 3/21 (14.3%) | 8/50 (16.0%) | 6/24 (25.0%) | 0.001† |
RVO, retinal vein occlusion; wAMD, wet age-related macular degeneration.
According to one-way ANOVA with the Bonferroni post test.
†According to the Chi-square test.
Findings in the fellow eye of acute-onset vitreous hemorrhage (VH) of preoperatively unknown origin.
| All | RVO | wAMD | Retinal break |
| |
|---|---|---|---|---|---|
| LogMAR BCVA | 0.19 ± 0.46 | 0.17 ± 0.38 | 0.44 ± 0.45 | 0.05 ± 0.09 | <0.001 |
| Fundus finding | |||||
| Normal | 131/169 (77.5%) | 61/74 (82.4%) | 4/21 (19.0%) | 45/50 (90.0%) | <0.001† |
| Drusen | 21/169 (12.4%) | 5/74 (6.8%) | 15/21 (71.4%) | 1/50 (2.0%) | <0.001† |
| Retinal break | 5/169 (3.0%) | 0/74 (0.0%) | 0/21 (0.0%) | 4/50 (8.0%) | 0.020 |
| RVO | 1/169 (0.6%) | 3/74 (4.1%) | 1/21 (4.8%) | 0/50 (0.0%) | 0.334 |
| Others | 8/169 (4.7%) | 5/74 (6.8%) | 1/21 (4.8%) | 0/50 (0.0%) | 0.177 |
BCVA, best-corrected visual acuity; RVO, retinal vein occlusion; wAMD, wet age-related macular degeneration; AMD, age-related macular degeneration.
According to one-way ANOVA with the Bonferroni post test.
†According to the Chi-square test.
Risk scoring system used to predict poor visual outcomes after vitrectomy in patients with acute-onset vitreous hemorrhage (VH) of preoperatively unknown origin.
| Categories | Reference value ( | Beta |
Beta( | Point = beta( | Score |
|---|---|---|---|---|---|
| Age | |||||
| 24–40 | 33.5 ( | −0.004 | 0 | 0 | 0 |
| 40–49 | 44.5 | −0.043 | −1.0000854 | −1 | |
| 50–59 | 54.5 | −0.082 | −1.9092539 | −2 | |
| 60–69 | 64.5 | −0.121 | −2.8184224 | −3 | |
| >70 | 78.5 | −0.176 | −4.0912583 | −4 | |
| Preoperative LogMAR BCVA in affected eye | |||||
| 0–0.5 | 0.25 ( | −0.112 | 0 | 0 | 0 |
| 0.5–1.0 | 0.75 | −0.056 | −1.3076873 | −1 | |
| 1.0–1.5 | 1.25 | −0.112 | −2.6153746 | −3 | |
| 1.5–2.0 | 1.75 | −0.169 | −3.9230619 | −4 | |
| 2.0–2.5 | 2.25 | −0.225 | −5.2307491 | −5 | |
| 2.5–3.0 | 2.75 | −0.281 | −6.5384364 | −7 | |
| Preoperative LogMAR BCVA in the fellow eye | |||||
| 0–0.5 | 0.25 ( | −0.096 | 0 | 0 | 0 |
| 0.5–1.0 | 0.75 | −0.048101477 | −1.118639 | −1 | |
| 1.0–1.5 | 1.25 | −0.096202955 | −2.237278 | −2 | |
| 1.5–2.0 | 1.75 | −0.144304432 | −3.355917 | −3 | |
| 2.0–2.5 | 2.25 | −0.19240591 | −4.474556 | −4 | |
| 2.5–3.0 | 2.75 | −0.240507387 | −5.5931951 | −6 | |
| Drusen in the fellow eye | |||||
| no | 0 ( | −0.358 | 0 | 0 | 0 |
| yes | 1 | −0.358 | −8.3255814 | −8 |
BCVA, best-corrected visual acuity.
W: reference value.
Beta: beta coefficients used in the logistic regression model.
B: number of regression units that correspond to 1 point. We let B = 0.043 reflect the increase in risk associated with 10-year increases in age.
Risk scores of study patients with acute-onset vitreous hemorrhage (VH) of preoperatively unknown origin.
|
Score | Estimated chance having good vision | All included patients | |
|---|---|---|---|
| Snellen visual acuity < 20/200 after vitrectomy (no.) | Snellen visual acuity ≥ 20/200 after vitrectomy (no.) | ||
| 0 | 0.448 | ||
| 1 | 0.459 | ||
| 2 | 0.470 | 1 | 0 |
| 3 | 0.480 | ||
| 4 | 0.491 | 1 | 0 |
| 5 | 0.502 | 1 | 0 |
| 6 | 0.512 | 2 | 2 |
| 7 | 0.523 | 1 | 1 |
| 8 | 0.534 | 3 | 4 |
| 9 | 0.545 | 1 | 2 |
| 10 | 0.555 | 2 | 1 |
| 11 | 0.566 | ||
| 12 | 0.576 | 2 | 1 |
| 13 | 0.587 | 0 | 1 |
| 14 | 0.597 | 1 | 2 |
| 15 | 0.608 | 2 | 4 |
| 16 | 0.618 | 6 | 17 |
| 17 | 0.628 | 1 | 37 |
| 18 | 0.638 | 0 | 29 |
| 19 | 0.648 | 0 | 19 |
| 20 | 0.657 | 0 | 9 |
| 21 | 0.667 | 0 | 5 |
| 22 | 0.677 | 0 | 6 |
| 23 | 0.686 | 0 | 3 |
| 24 | 0.695 | 0 | 2 |
| 25 | 0.704 | ||
| Total | 24 | 145 | |
Estimated risk score after 25 was added to prevent a negative integer as the risk score.
Figure 3ROC curves of the scoring system used to predict the visual prognosis of acute-onset VH of preoperatively unknown origin. The solid line shows the ROC curves of four variables (age, baseline BCVA of the affected eye, baseline BCVA of the unaffected eye, and age-related macular changes in the fellow eyes), which were significantly associated with poor visual acuity following vitrectomy. The dashed line shows the ROC curve of the scoring system. The AUC of the scoring system was 0.907 (95% CI = 0.853–0.948).